Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study To Assess Response to Eptacog Beta iN Patients With Glanzmann THromboasthenia (STRENGTH )

NCT07136857 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT07136857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07136857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study To Assess Response to Eptacog Beta iN Patients With Glanzmann THromboasthenia (STRENGTH )
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Recruiting
Start date
October 2, 2025
Completion date
December 31, 2026
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glanzmann thrombasthenia